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The gene cluster for the bipyridyl compound col-
lismycin was characterized from Streptomyces sp.
CS40. Sequence analysis of a 46.7 kb DNA region
revealed 27 open reading frames, 23 of which are
involved in collismycin biosynthesis. Eight inser-
tional inactivation mutants were generated in the
sequenced region to prove its involvement in col-
lismycin biosynthesis, define the boundaries of the
cluster, functionally characterize some genes, and
isolate two biosynthetic intermediates. A model for
collismycin biosynthesis—which includes the con-
version of lysine into picolinic acid, participation of
a polyketide synthase-non-ribosomal peptide syn-
thetase system, and some further modifications—is
proposed. The biosynthetic pathway would include
an unusual NRPS-mediated incorporation of a
cysteine residue, possibly through a Michael addi-
tion and followed by the extension of the peptide
chain by leucine incorporation and later removal by
amidohydrolase.
INTRODUCTION
Among natural products synthesized by microorganisms, three
main structural families constitute the great majority of bioactive
compounds, both based on structural diversity and also in appli-
cability: polyketides (PK), nonribosomal peptides (NRP), and
hybrid PK-NRP (Newman and Cragg, 2007). Polyketides are
synthesized by a sequential set of reactions catalyzed by polyke-
tide synthases (PKS). The carbon skeleton of these compounds
is biosynthesized by stepwise decarboxylative Claisen-type
condensation of acyl-CoA precursors that are further modified.
Three types of PKS are known to date: type I, multifunctional
enzymes organized intomodules, each harboring a set of distinct
activities responsible for the catalysis of one cycle of polyketide
chain elongation; type II, multienzyme complexes that carry out
a single set of iteratively acting activities; and finally, type III,Chemistry & Biology 19, 3iteratively acting condensing enzymes (Wenzel and Mu¨ller,
2005; Gokhale et al., 2007; Van Lanen and Shen, 2008; Khosla,
2009). Nonribosomal peptides are small peptide molecules
synthesized by nonribosomal peptide synthetases (NRPS) using
proteinogenic and nonproteinogenic amino acids as monomeric
building blocks, including D-amino acids and other carboxylic
acids. The amino acid monomers incorporated by NRPS
assembly lines are aminoacyl-AMPmixed anhydrides that follow
the same chemical logic as type I PKS for chain elongation and
then are modified based on the program encoded by different
domains present in NRPS modules, which can include epi-
merization, methyltransferase, reductase, or oxidase activities
(Walsh, 2004; Sieber and Marahiel, 2005; Fischbach and Walsh,
2006; Koglin and Walsh, 2009; Strieker et al., 2010). Finally, the
hybrid PK-NRP compounds contain both polyketide and peptide
moieties. In these compounds, usually the PK moiety is syn-
thesized by a type I PKS (modular PKS); therefore, in the bio-
synthesis of PK-NRP compounds, multifunctional enzymes
with an assembly line-like structure are responsible for the
generation of the mixed PK-NRP chain (Du and Shen, 2001).
Within natural products synthesized by microorganisms, the
bipyridyl family of compounds has not been yet studied in detail.
Representatives of this family are SF2738A-F (Gomi et al., 1994),
pyrisulfoxins (Tsuge et al., 1999), collismycins (Shindo et al.,
1994), and caerulomycins (Funk and Divekar, 1959; McInnes
et al., 1977, 1978). All these compounds contain a 2,20-bipyridyl
ring system, which is further modified with some postbipyridyl
tailoring modifications (Figure 1A). Early biosynthetic studies
using labeled precursors suggested that lysine-derived picolinic
acid was a biosynthesis precursor (McInnes et al., 1979; Vining
et al., 1988). Members of this family (including collismycin A)
have been shown to exhibit antibacterial, antifungal, and cyto-
toxic activities (Gomi et al., 1994; Stadler et al., 2001), and they
also show potentiality as anti-inflammatory agents through the
binding to the dexamethasone-glucocorticoid receptor (Shindo
et al., 1994) or as neuroprotectant agents by reducing oxidative
stress in neurons (Martinez Gil et al., 2007).
Here we report the isolation of the gene cluster for collismycin
A biosynthesis from Streptomyces sp. CS40, a strain isolated
from the leaf-cutting ant Acromyrmex octospinosus. Insertional
inactivation experiments provided evidence for the involvement99–413, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 399
Figure 1. The Collismycin Gene Cluster
(A) Chemical structure of collismycin A and (B) genetic organization of the collismycin gene cluster in Streptomyces spp. CS40. White arrows indicate genes that
are not involved in collismycin biosynthesis. Black and gray arrows indicate genes involved in collismycin biosynthesis. Gray arrows indicate genes inactivated in
CLMM1, CLMAH, and CLM12 mutants. cos3b11 and cos1c3 represent cosmids containing the sequenced region. Asterisk indicates the BamHI fragment used
for generating mutant CLM12. BamHI sites are numbered. EV, EcoRV; N, NcoI; EI, EcoRI; P, PvuI; C, ClaI, restriction sites used for cloning purposes.
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lished the boundaries of the gene cluster. We also show experi-
mental evidence of an interesting system for the formation of the
second pyridine ring involving the incorporation and further
removal of a leucine residue.
RESULTS
Isolation and Characterization of the Collismycin Gene
Cluster
Work in our laboratory on the search for novel bioactive
compounds prompted us to look for actinomycetes from the
cuticle of leaf-cutting ants isolated from four different nests in
Lambayeque, Peru´. From a total of 197 strains isolated and iden-
tified as members of the actinomycetes family, we selected
several strains producing interesting bioactive compounds
according to their bioactive profile (unpublished data). Four of
these strains were found to produce a small molecule that was i-
dentified by nuclear magnetic resonance (NMR) and mass
spectrometry (MS) as collismycin A. We selected one of these
strains, named Streptomyces sp. CS40, for the isolation and
characterization of the gene cluster. Based on previous reports
suggesting lysine-derived picolinic acid as a biosynthetic
precursor, the possible participation of a lysine aminotransferase
(LAT) in collismycin biosynthesis in this strain was evaluated.
Two different LATs have been described to participate in the
biosynthesis of secondary metabolites in actinomycetes. On
one hand, lysine 2-aminotransferases (LAT2) involved in the
biosynthesis of virginiamycin S (Namwat et al., 2002) and nikko-
mycin D (Bruntner and Bormann, 1998) and, on the other
hand, a lysine 6-aminotransferase (LAT6) involved in the biosyn-400 Chemistry & Biology 19, 399–413, March 23, 2012 ª2012 Elseviethesis of cephamycin C (Coque et al., 1991). Degenerated oligo-
nucleotides based on amino acid sequences of LAT2 and LAT6
genes were designed and used in polymerase chain reaction
(PCR) amplification reactions using chromosomal DNA from
Streptomyces sp. CS40 as template. A 565 bp PCR product
was obtained with the LAT2 primers, but no amplification
product was found with the LAT6 primers. Sequencing of the
PCR product revealed clear similarities of the partially encoded
protein with LAT2 enzymes, such as NikC from the nikkomycin
pathway (53% identity in the sequenced region) and VisA
from the virginiamycin pathway (47% identity in the sequenced
region).
To isolate the collismycin gene cluster, we screened a library
of Streptomyces spp. CS40 genomic DNA in cosmid pWE15
by in situ colony hybridization using the 565 bp PCR product
as a probe. Three positive clones were isolated and verified by
Southern hybridization. One of these cosmids, cos1C3, was
submitted to partial sequencing of both ends of different BamHI
fragments. Analysis of the deduced products of the different orfs
indicated that they would code for enzymatic functions required
for collismycin biosynthesis, including PKS and NRPS genes
(data not shown). One of these BamHI fragments (sites 13–14,
Figure 1B) was cloned into the suicide vector pOJ260 generating
pOJB12, and this plasmid was used for gene disruption experi-
ments. The resultant mutant CLM12 did not produce collismycin
A when compared with the wild-type strain (Figure 2), indicating
that the gene sequence within this BamHI fragment is involved in
collismycin biosynthesis.
Cos1C3 and a 7,752 bp EcoRV-HindIII fragment overlapping
the left-hand side of this cosmidwere sequenced obtaining infor-
mation of the complete gene cluster. The nucleotide sequence ofr Ltd All rights reserved
Figure 2. UPLC Analysis of Ethyl Acetate Extracts
of Streptomyces spp. CS40and Mutant CLM12
(A) Streptomyces spp. CS40 and (B) mutant CLM12. The
arrow indicates the UPLC mobility of collismycin A.
Chemistry & Biology
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sion number HE575208). Sequence analysis and comparisons
with databases revealed the presence of 27 orfs (Figure 1B;
Table 1), all of them showing high GC content and GC bias at
the third codon position that is characteristic of Streptomyces
genes. Analysis of the deduced products of the different orfs
showed the similarities shown in Table 1. Two TTA codons
were found (one in clmT2 and another in clmR2), implying an
upper level of regulation during collismycin biosynthesis by
some homolog to the pleiotropic regulatory gene bldA encoding
a tRNA-Leu (Chater and Chandra, 2008).
Delimiting the Boundaries of the Collismycin Cluster
It was initially assumed that most of the 27 orfs could be involved
in collismycin biosynthesis. This was based on the deduced
functions of the gene products and on tentative roles for their
products in collismycin biosynthesis. In order to determine
the boundaries of the cluster, several orfs at both sides of the
sequenced region (orf1, clmR1, orf2, orf3, and orf4) were
knocked out by insertional inactivation. On the left-hand side,
mutants in which either a gene coding for an helicase (orf1)
or a gene coding for a TetR family regulatory protein (clmR1)
were inactivated at the same level of the wild-type strain.
From this result, it can be deduced that clmR1 is not involved
in collismycin biosynthesis. However, the clmR1 mutant started
collismycin biosynthesis earlier than did the wild-type strain,Chemistry & Biology 19, 399–413, March 23suggesting a role for this gene in collismycin
biosynthesis. On the right-hand side, three
genes (orf2, orf3, and orf4) were initially
assumed to participate in collismycin biosyn-
thesis based on their similarities to P450 mon-
oxygenase (orf2), ArsR regulatory (orf3), and
NRPS (orf4) genes. However, individual inacti-
vation of these three genes did not affect
collismycin biosynthesis (data not shown).
According to these results we considered at
the moment that all these four genes were prob-
ably not involved in collismycin biosynthesis.
Moreover, in the course of these studies, we
became aware of the existence of a highly
similar cluster in a region of the recently
sequenced genome of Streptomyces roseo-
sporus NRRL15998 (Broad Institute accession
number ABYB01000000). This region, which
has not been annotated as a putative collismy-
cin cluster, showed a similar genetic organiza-
tion to that of the collismycin cluster with
similarities at the amino acid level between
gene products as high as 96%–99%. Because
of this high similarity, we assumed that the
S. roseosporus cluster was also involved in
collismycin biosynthesis and therefore similaractivities should be present in both clusters. Streptomyces
sp. CS40 orf1, orf2, orf3, and orf4 were not present in
S. roseosporus; however, both strains shared clmR1 homologs
as the last gene on the left-hand side of the clusters and clmT
homologs at the right-hand side of the clusters. Based on this
information, we propose clmR1 and clmT as the boundaries of
the collismycin cluster, thus delimiting the clm cluster to a region
of 36.5 kb.
Genes Involved in Picolinic Acid Biosynthesis
and Its Activation to Picolinyl-CoA
Three genes in the cluster, clmL, clmS, and clmAL are probably
involved in the biosynthesis of picolinic acid from L-lysine, its
activation to picolinyl-CoA, and its loading to the PKS-NRPS
hybrid protein ClmN1. The ClmL protein strongly resembles
NikC of the nikkomycin pathway in S. tendae (Bruntner and
Bormann, 1998) and VisA of the virginiamycin S pathway
in S. virginiae (Namwat et al., 2002). These two proteins
have been shown to code for a LAT2, converting L-lysine into
1-piperidine-2-carboxylic acid. The ClmS protein showed clear
similarities to monomeric sarcosine oxidases, such as NikD
of the nikkomycin pathway in S. tendae (Bruntner et al., 1999).
Sarcosine oxidases catalyze the oxidation of sarcosine to
formaldehyde, glycine, and H2O2 using FAD. ClmS exhibits an
ADP-bab-binding fold fingerprint motif that is important for the
interaction with FAD (Nishiya and Imanaka, 1996), and it also, 2012 ª2012 Elsevier Ltd All rights reserved 401
Table 1. Proposed Functions for Collismycin Biosynthesis Genes
Gene aa Proposed Function in Collismycin Biosynthesis
Similar Protein, Origin, (% Identity / Similarity), Accession
Number
orf1 563 DEAD/DEAH box helicase domain-containing protein,
Streptomyces viridochromogenes DSM 40736, (85/90),
ZP_07307194
clmR1 186 TetR family transcriptional regulation TetR family transcriptional regulator Streptomyces griseus
subsp. griseus NBRC 13350 (86/95), YP_001827902.1
clmT1 578 Transmembrane ABC family collismycin transport Putative ABC transporter ATPase and permease component
Streptomyces griseus subsp. griseus NBRC 13350, (90/94),
YP_001827903.1
clmT2 587 Transmembrane ABC family collismycin transport Putative ABC transporter ATPase and permease component
Streptomyces griseus subsp. griseus NBRC 13350, (91/95),
YP_001827904.1
clmT3 323 Transmembrane ABC family collismycin transport Putative ABC transporter solute-binding protein
Streptomyces griseus subsp. griseus NBRC 13350, (79/88),
YP_001827905.1
clmT4 328 Transmembrane ABC family collismycin transport Iron ABC transporter Streptomyces griseus subsp. griseus
NBRC 13350, (86,92), YP_001827906.1
clmT5 262 Transmembrane ABC family collismycin transport Putative ABC transporter ATP-binding protein Streptomyces
griseus subsp. griseus NBRC 13350, (87/90),
YP_001827907.1
clmR2 169 LuxR family transcriptional regulation Two component transcriptional regulator, LuxR family
Thermaerobacter marianensis DSM 12885, (56/76),
YP_004102054.1
clmM2 343 Methylation AzicL, Kibdelosporangium sp. MJ126-NF4, (44/59),
ADB02856.1
clmD2 533 Dehydrogenation Putative dehydrogenase and domain with unknown function
Streptomyces albaduncus (56/69) CBH32104.1. TamL,
Streptomyces sp. 307-9, (52/65), ADC79636
clmAT 545 Oxime generation Diaminobutyrate-pyruvate aminotransferase, Streptomyces
coelicolor A3(2), (55/70), NP_630377.1
clmM1 329 Methylation OxyF, Streptomyces rimosus, (52/70), AAZ78330
clmG1 463 Dehydrogenation GriD, Streptomyces griseus, (36/46), BAF36646
clmG2 344 Dehydrogenation GriC, Streptomyces griseus, (42/58) BAF36645
clmM 403 Reduction FAD-dependent oxidoreductase Ktedonobacter racemifer
DSM 44963 (47/63) ZP_04696966.1
clmAH 414 Amidohydrolase Amidohydrolase Salinispora arenicola CNS-205 (53/65)
YP_001536995.1
clmAL 563 Picolinic acid activation NikE, Streptomyces tendae, (52/61), CAB46535
clmP 87 PKS/NRPS loading Acyl carrier protein Oscillatoria sp. PCC 6506 (39/60)
ZP_07114031.1
clmL 459 Picolinic acid biosynthesis NikC, Streptomyces tendae, (57/71), CAA75797
clmS 394 Picolinic acid biosynthesis NikD, Streptomyes tendae, (59/69), CAB46534
clmN1 2553 PKS-NRPS CurF, Lyngbya majuscula 3L, (43/59), AAT70101
clmN2 1092 NRPS Nonribosomal peptide synthetase, Microcystis aeruginosa
K-139, (33/53), BAH22763
clmD1 395 Dehydrogenation Acyl-CoA dehydrogenase Acidobacterium capsulatum
ATCC 51196, (47/62), YP_002755437.1
clmT 243 NRPS intermediate release Putative type II thioesterase Cyanothece sp. ATCC 51142
(43/59) YP_001802837.1
orf2 408 Cytochrome P450 Streptomyces sviceus ATCC 29083 (78/86)
ZP_06921933.1
orf3 202 Conserved hypothetical protein, Streptomyces hygroscopicus
ATCC 53653, (39/48), ZP_07294271.1
orf4 1363 Nonribosomal peptide synthetase/polyketide synthase
Myxococcus xanthus DK 1622 (43/57), YP_631961.1
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Figure 3. Sequence Alignments between Motifs of ClmN1 and ClmN2 with Conserved Motifs of Several PKS/NRPS Domains
(A) ACP-PCP domains alignment. ACP-PCP (cons.) represents the consensus sequence for acyl and peptidyl carrier proteins.
(B) KS domain alignment. KS (cons.) represents consensus sequence for ketosynthase domain.
(C) AT domains alignment, where AT methylmalonylCoA indicates consensus sequence for propionate incorporation, and AT malonylCoA indicates consensus
sequence for acetate incorporation.
(D) Condensation/cyclization domain alignment. Cy (cons.) represents consensus sequences for condensation/cyclization domain.
(E) Adenylation domain alignment. A Cys (cons.), A Gln (cons.), A Thr (cons.), and A (Leu (cons.) represents consensus Stachelhaus sequences for cysteine,
glutamine, threonine, and leucine incorporation, respectively.
(F) Condensation domain alignment. C (cons.) represents consensus sequence for condensation domain.
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part of the active site of the enzyme (Nishiya et al., 1995). The
ClmAL protein shows the presence of an AMP-binding domain,
characteristic of the acetyl-CoA synthetase-like superfamily.
Proteins with an AMP-binding domain contain a consensus
sequence involved in ATP binding and amino acid adenylation.
ClmAL matches with all consensus core sequences described
for this domain (de Cre´cy-Lagard et al., 1997), and the amino
acid sequence between positions 213 and 222 (LSGGTTGPPK)
contains the signature characteristic of active AMP-binding
domains (LSGGxTxxxK). According to this information, the
consecutive action of ClmL, ClmS, and ClmAL would convert
L-lysine into activated picolinyl-CoA.
Genes Involved in the Formation of the Bipyridyl Ring
Four PKS-NRPS or related genes have been identified in the
cluster: clmP, clmN1, clmN2, and clmT. The deduced sequenceChemistry & Biology 19, 3of clmP shows high similarity (above 60%) and identity (above
39%) with predicted acyl carrier proteins (ACP) from different
organisms. ClmP also contains the core motif (LGLSS) present
in ACPs (LGXDS) with the active serine residue (Marahiel et al.,
1997; Figure 3A). ACPs act as ‘‘swinging arms’’ for the attach-
mentof activated fatty acids, allowing its elongation andprocess-
ing by PKS proteins. These domains are usually encoded within
the PKS, but sometimes ACPs act as stand-alone domains, like
AcmD in actinomycin biosynthesis (Pfennig et al., 1999). We
propose ClmP as a free-standing ACP charging picolinic acid
from the acyl-CoA forming enzyme ClmAL to ClmN1.
Genes clmN1 and clmN2 would encode a hybrid PKS-NRPS
and NRPS proteins, respectively. Analysis of the deduced amino
acid sequence of ClmN1 reveals the presence of seven domains
organized into two modules: a PKS extender module and a
NRPS elongation module (Figure 4). The PKS extender module
contains ketosynthase (KS), acyltransferase (AT), and ACP99–413, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 403
Figure 4. Scheme Showing the Multi-
Enzymatic Hybrid PKS-NRPS Complex
Formed by ClmP, ClmN1, and ClmN2 and
the Hypothetical Reactions that It Catalyzes
The question marks indicate that the enzymes
catalyzing the reduction steps following malonyl-
CoA incorporation have not been yet identified.
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conserved residues present in consensus KS domains (Fig-
ure 3B; Aparicio et al., 1996; Chang et al., 2004). The AT domain
contains the active site motif (GHSxG; Reeves et al., 2001) and
the substrate specificity signature for malonyl-CoA (Figure 3C;
Reeves et al., 2001). The NRPS module in ClmN1 contains
condensation/cyclization (Cy), adenylation (A), peptidyl carrier
protein (PCP), and epimerizarion (E) domains. The ClmN1
NRPS module shows a high similarity with the CurF NRPS
module (44% identity and 60% similarity), both having a similar
organization, except that the E domain present in ClmN1 was
absent in CurF. CurF is a hybrid PKS-NRPS involved in curacin
A biosynthesis in the cyanobacterium Lyngbya majuscule. The
NRPS module in CurF elongates the growing chain by
condensing a cysteine residue to generate a thiazoline ring
(Chang et al., 2004). A domain contains a ten amino acids signa-
ture determining substrate specificity, known as Stachelhaus
sequence, and it is possible to predict the possible amino acid
loaded by comparing this sequence with other domains (Sta-
chelhaus et al., 1999). Stachelhaus analysis of the A domain of
ClmN1 (DLFNLSLVWK) suggests that this module incorporates
a cysteine residue (Figure 3E).
ClmN1 NRPS module contains a cyclization domain (Cy). This
type of domain is usually involved in the generation of hetero-
cyclic derivatives of cysteine, threonine, or serine and their
condensation into the nascent nonribosomal peptide. ClmN1
Cy domain contains a sequence (DLLVADVSS) described as the
core signature motif of the Cy domain (DxxxxDxxS; Di Lorenzo
et al., 2008). Additionally, the ClmN1 Cy domain sequence
contains other specific Cy consensus sequences also present
in the CurF Cy domain (Figure 3D; Chang et al., 2004).
Analysis of the ClmN1 NRPS module predicts the presence of
an E domain. These domains are usually associated with the
modification of the incorporated amino acid from an L-amino
acid into a D-amino acid (Marahiel et al., 1997). Although the404 Chemistry & Biology 19, 399–413, March 23, 2012 ª2012 Elsevier Ltd All rights reservedpresence of the E domain in ClmN1 is
suggested based on sequence analysis,
this domain lacks the active site motif
present in functional E domains
(HHxxxDxVSW; de Cre´cy-Lagard et al.,
1997). We therefore propose that the
ClmN1 E domain is not active or is not
acting as a canonical E domain.
The clmN2 gene would code for
a monomodular NRPS. It contains three
domains: C, A, and PCP. The C domain
contains the highly conserved coremotifs
C2 (RHExLRTxF) and C3 (HxxxDG) with
the active histidine residue (Figure 3F;
Marahiel et al., 1997). Analysis of the Adomain does not match any of the motifs present in databases
and thus makes it difficult to predict the amino acid used as
substrate. However, the fact that the C domain contains an
active site suggested that a second amino acid should be incor-
porated by the ClmN2 protein. ClmN2 also contains a putative
PCP domain containing the conserved core sequence for ACP/
PCP domains (Figure 3A).
The gene clmT encodes a type II thioesterase (TE) domain.
Stand-alone type II TEs are often encoded within NRPS gene
clusters and are proposed to act by removing incorrectly loaded
amino acids from PCP domains of NRPS proteins or removing
acetyl groups from ACP domains to regenerate free thiol groups
(Schwarzer et al., 2002). However, recent studies reveal that
stand-alone type II TEs could also act by releasing an interme-
diate product from ACP for subsequent modifications (Whicher
et al., 2011). Since ClmN1 and ClmN2 lack the TE domain, we
propose that ClmT could be involved in releasing the growing
PK-NRP chain from ClmN2.
Three other genes (clmM, clmD1, and clmD2) in the cluster
could participate in the heterocyclization of the second ring
and thus form the 2,20-bipyridyl structure. Blast analysis reveals
that ClmM shows high similarity (above 40% identity and 60%
similarity) with putative FAD-dependent oxidoreductases and
monoxygenases. In addition, ClmM contains an UbiH domain
present in 2-polyprenyl-6-methoxyphenol hydroxylases and
related FAD-binding oxidoreductases. This suggests that clmM
could code for a putative monoxygenase. The ClmD1 predicted
sequence shows high homology (above 45% identity and 60%
similarity) with predicted acyl-CoA dehydrogenases from dif-
ferent organisms. The predicted sequence contains an acyl-
CoA dehydrogenase domain. This domain is typically found in
FAD-dependent oxidases reducing CoA-bound substrates.
The ClmD2 sequence shows high homology with TamL (52%
identity and 65% similarity), a protein probably involved in oxida-
tive tailoring modifications during tirandamycin biosynthesis
Chemistry & Biology
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larity), a FAD-dependent secondary alcohol oxidase involved in
spinosin biosynthesis (Kim et al., 2007). It shows the presence
of a FAD-binding domain (residues 43 to 123), which is involved
in a variety of oxidation reactions (Mattevi et al., 1997) and is
usually present in enzymes using FAD as cofactor, mainly oxido-
reductases. The exact roles of ClmM, ClmD1, and ClmD2 in
collismycin biosynthesis are not clear at the moment, although
at least two oxidations and one dehydration steps are necessary
for heterocyclization to generate the 2,20-bipyridyl ring. These
enzymes could participate in these reactions.
Genes Involved in Further Modifications
Upon formation of the bipyridyl ring, several additional genes
would introduce further chemical modifications to generate the
final product collismycin A. Two genes in the cluster (clmM1
and clmM2) would code for methyltransferases. Analysis of the
amino acid sequence of ClmM1 and ClmM2 shows that both
would code for S-adenosylmethionine-dependent methyltrans-
ferases. However, ClmM1 and ClmM2 are significantly different,
only sharing 37% identity. ClmM1 is homolog to OxyF (52%
identity and 70% similarity), which is probably involved in
C-methylation during oxytetracycline biosynthesis (Zhang
et al., 2006). On the other hand, the closest homolog to ClmM2
is AzicL (44% identity and 59% similarity), responsible for an
O-methylation during azicemicins biosynthesis (Ogasawara
and Liu, 2009). Based on this information, we propose that
ClmM2 could be involved in the generation of the methoxy group
present in position 4 in collismycin and ClmM1 could be respon-
sible for catalyzing a methylation event necessary for interme-
diate rearrangement during earlier steps of the biosynthesis.
This role for ClmM1 was confirmed by insertional inactivation
(see subsection Unusual Incorporation of a Leucine Residue
and Its Further Removal during Biosynthesis).
The deduced product of clmAH shows high similarity with
a putative amidohydrolase from Salinispora arenicola (52%
identity and 64% similarity; US DOE Joint Genome Institute,
YP_001536995.1). The amidohydrolase family includes metallo-
dependent enzymes involved in the hydrolysis of C-N bonds
(both peptidic and nonpeptidic) by the nucleophilic attack of
a deprotonated molecule of water. ClmAH shares with several
members of this family a conserved metal binding site, involving
four histidines and one aspartic acid residue, which are not near
each other in the amino acid sequence but are very close in the
tridimensional structure of the protein (Holm and Sander, 1997).
The role of ClmAH in collismycin biosynthesis was initially not
very clear. It was difficult to anticipate which amide bond would
be hydrolyzed by this protein, but it was later on established by
insertional inactivation (see subsection Unusual Incorporation of
a Leucine Residue and Its Further Removal during Biosynthesis).
ClmG1 shows homology with NAD(P)-dependent aldehyde
dehydrogenases, such as GriD from S. griseus subsp. griseus
(55% identity 67% similarity). Next to clmG1 and in the same
orientation, clmG2 would code for a protein homologous to dif-
ferent AMP-binding proteins, such as GriC also from S. griseus
subsp. griseus (49% identity and 63% similarity). GriC and
GriD have been reported to act together as a carboxylic acid
reductase involved in the conversion of 3-amino-4-hydroxyben-
zoic acid (3,4-AHBA) to 3-amino-4-hydroxybenzaldehyde (3,4-Chemistry & Biology 19, 3AHBAL) during the biosynthesis of grixazone in S. griseus. In
that reaction, GriC was proposed to convert 3,4-AHBA to an
acyl-AMP intermediate, which is later reduced to 3,4-AHBAL
by GriD with the use of NAD(P)H (Suzuki et al., 2007). Their
homology to ClmG1 and ClmG2 suggest that these enzymes
could catalyze a similar reaction during collismycin biosynthesis,
reducing a 2,20-bipyridine intermediate with a carboxylic group
to an aldehyde and thus preparing that position for the introduc-
tion of the oxime group. Finally, ClmAT predicted amino acid
sequence shows the presence of an acetyl ornithine aminotrans-
ferase domain. This domain belongs to aminotransferase
class-III family and enzymes containing this domain are involved
in transamination or decarboxylation of basic amino acids and
their derivatives in pyridoxal phosphate-dependent reactions.
ClmAT shows high identity with putative diaminobutyrate-
pyruvate aminotransferases (above 50% identity and above
70% similarity) and with BatP (28% identity and 47% similarity),
aminotransferase involved in kalimantacin/batumin-related pol-
yketide biosynthesis in Pseudomonas fluorescens (Mattheus
et al., 2010). We propose ClmAT could participate in the forma-
tion of the oxime group in collismycin A biosynthesis.
Regulation and Secretion
Two possible regulatory genes, clmR1 and clmR2, and five
putative transport genes, clmT1 to clmT5, are located on the
left-hand side of the collismycin cluster. clmR1 would code for
a transcriptional regulator of the TetR family. It contains the usual
N-terminal helix-turn-helix (HTH) DNA binding domain that is
characteristic of this family, involving three a helices and part
of the fourth one. TetR regulators act mainly as transcriptional
repressors, and they control drug resistance and antibiotic
production, as well as other metabolic processes (Ramos
et al., 2005). Inactivation of clmR1 does not abolish collismycin
biosynthesis but rather anticipates the starting time for collis-
mycin biosynthesis (data not shown). The second regulatory
gene, clmR2, shows high homology with LuxR-family tran-
scriptional regulators. They all have a C-terminal HTH DNA
binding domain that forms a four-helical structure, whereas the
N-terminal region of the protein usually contains an auto-inducer
binding domain or a response regulator domain (Aravind et al.,
2005). Unlike them, ClmR2 does not show any homology or iden-
tifiable domain in its N-terminal region, making this protein more
similar to GerE, a small transcriptional regulator from Bacillus
subtilis, which represents the simplest member of this family,
since it lacks the usual ‘‘receiver’’ domain and is only composed
of the HTH DNA binding domain (Ducros et al., 2001).
Genes clmT1 and clmT2 code for proteins homologous to
ABC transporters, in which the hydrophobic transmembrane
domain and the ATP-binding domain are fused in a single poly-
peptide. The hydrophobic domain is located in the N-terminal
region of the protein and would encode six transmembrane
helices, and the nucleotide binding domain is in the C-terminal
region and contains theWalker A andWalker Bmotifs character-
istic of the ATP-binding cassette family (Me´ndez and Salas,
2001). These genes are located together and transcribed in the
same direction, opposite to that of the surrounding genes. The
products of these two genes could form a transport system
with two transmembrane domains and two nucleotide binding
domains forming a heterodimer (Kos and Ford, 2009; Me´ndez99–413, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 405
Figure 5. Isolation of Collismycin SC and Collismycin SN
(A) UPLC chromatogram of extracts of mutant CLMAH and chemical structure of collismycin SC (col SC) and its absorption spectrum and mass analysis. For
comparison, UPLC retention of collismycin A (col A) is indicated.
(B) UPLC chromatogram of extracts of mutant CLMM1 and chemical structure of collismycin SN (col SN) and its absorption spectrum and mass analysis of
collismycin SN (col SN). For comparison, UPLC retention of collismycin A (col A) is indicated.
See also Tables S1 and S2.
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similarity to ABC transporter solute-binding proteins (SBPs),
such as FepB-like proteins. Structurally, ClmT3 would be similar
to cluster A SBPs involved in the binding and uptake of ferric
siderophores and several metal ions (Berntsson et al., 2010).
The gene clmT4 would code for the permease component of
the transport system, similar to FepD-like proteins. It contains
nine predicted transmembrane helices. The ClmT5 predicted
sequence shows high homology with the ATPase subunit of
ABC transporters involved in ferric iron uptake, such as FepC-
type proteins. It contains the characteristic nucleotide-binding
domain with one Walker A and one Walker B motif (Me´ndez
and Salas, 2001). The fact that these three genes (clmT3,
clmT4, and clmT5) are similar to different components of the
Fep transport system involved in the uptake of chelated ferric
iron-siderophore complexes (Stephens et al., 1995) and also to
three consecutive genes from Frankia sp. CcI3 (YP_483314.1,
YP_483316.1, and YP_483315.1, with levels of identity/
homology of 31/47%, 53/70%, and 51/65%, respectively) sug-
gests that they could conform a single transport system. Further-
more, the hypothetic permease component of this system
(ClmT4), contains putative interaction residues with another
transmembrane component, a solute-binding protein (probably406 Chemistry & Biology 19, 399–413, March 23, 2012 ª2012 ElsevieClmT3) and an ATPase domain (possibly ClmT5), which re-
inforces the idea of a system integrated by three independently
coded proteins that interact with each other in order to form
a complete functional ABC system.
Unusual Incorporation of a Leucine Residue and Its
Further Removal during Biosynthesis
Asmentioned previously, a clear role for the ClmAH amidohydro-
lase was not initially anticipated based on the structure of collis-
mycin and on tentative models for its biosynthesis. We therefore
decided to generate a mutant in clmAH by gene replacement.
The resultant mutant CLMAH did not produce collismycin, but
it accumulated a compound that was not detected in the wild-
type strain (Figure 5A). MS analysis of this compound revealed
a surprisingly high molecular weight: 375 mass units versus
275 mass units for collismycin A. This compound was purified,
and its structure was elucidated by using one-dimensional (1D)
1H, two-dimensional (2D) 1H correlated spectroscopy (COSY)
1H, 13C heteronuclear single quantum coherence (HSQC)-
edited, and heteronuclear multiple bond correlation (HMBC)
nuclear magnetic resonance (NMR) experiments. A first analysis
allowed us to identify a 2,20-bipyridyl fragment identical to that
observed in the reference compound collismycin A. Thus, ther Ltd All rights reserved
Figure 6. Biotransformation Experiments with Collismycin SC and collismycin SN
(A) Mutant CLM12 grown in the presence of collismycin SC (col SC).
(B) Mutant CLM12 grown in the presence of collismycin SN (col SN).
(C) Mutant CLMM1 grown in the presence of collismycin SC (col SC).
(D) Mutant CLMAH grown in the presence of collismycin SN (col SN).
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(d 8.01), 50-H (d 7.52), and 60-H (d 8.72), typical of a mono-
substituted pyridine unit, which is connected with a second
tetra-substituted pyridine moiety (HMBC spectrum). These four
substituents were established as the 2-pyridyl unit, a hydroxyl
group (dC-OH 166.6), a methylthio group (dH 2.34, dC 17.7), and
an aminocarbonyl group (dH 8.70, dC 167.0). Moreover, the
1H-1H coupling of the amidic proton (NH) allowed us to
identify a leucine residue attached to this position, which was
responsible for the unexpected high molecular weight. This
compound was 6-[N-(1-Carboxy-3-methylbutyl)carbamoyl]-4-
hydroxy-5-methylthio[2,20-bipyridine] and was named as collis-
mycin SC.
The presence of this leucine residue in collismycin SC
(probably incorporated by the ClmN2 NRPS module) and its
absence in collismycin A suggests that a possible role for the
amidohydrolase ClmAH could be the removal of the leucine
residue before the formation of the oxime group. Interestingly,
collismycin SC only contains one of the two methyl groups in
collismycin; the methyl group at the sulfur atom is present but
the methyl group at the hydroxyl group is absent. We therefore
assumed that it was possible that one of the two methyltransfer-
ase genes could be responsible for the introduction of themethyl
group. Based on the similarities with methyltransferases in
databases, ClmM1 was a more likely candidate. Inactivation of
ClmM1bygene replacement rendered themutantCLMM1,which
did not produce collismycin but accumulated a compound,
showing also higher mass than collismycin A (359 mass units
versus 275 mass units for collismycin A; Figure 5B). We found inChemistry & Biology 19, 3this compound analogous chemical shifts and atom connectivity
to the NMR data of collismycin SC but without resonances from
the N-H amidic proton and the methylthio group. After careful
analysis, we established unambiguously that the pyridine unit of
this compound is fused with an N-substituted isothiazole ring.
This compound was 2-(1-Carboxy-3-methylbutyl)-3-oxo-5-(2-
pyridyl)-2,3-dihydro-1,2-thiazolo[4,5-b]pyridine and was named
collismycinSN.Fromherewededuced thatClmM1 is responsible
for the S-methylation, event causing the breakage of the N-S
bond and subsequent isothiazole ring opening.
The unexpected structures of collismycin SC and collismycin
SN prompted us to discard the possibility that they could be
shunt products and not real intermediates in collismycin biosyn-
thesis. With this aim, we carried out some biotransformation
experiments in which either collismycin SC or SN was fed to
the CLM12 (in which the clmN1 NRPS gene was inactivated),
the CLMAH, and the CLMM1 mutants. Both collismycin SC
and SN were efficiently converted into collismycin A by the
CLM12 mutant (Figures 6A and 6B). In addition, collismycin SC
was converted into collismycin A by the CLMM1 mutant (Fig-
ure 6C), whereas collismycin SN was converted into collismycin
SC by the CLMAH mutant (Figure 6D). These experiments
demonstrate that (1) collismycin SN and SC are biosynthetic
intermediates; (2) the amidohydrolase ClmAH acts after the
methyltransferase ClmM1; and (3) collismycin SN is the sub-
strate of ClmM1, which introduces the methyl group at the sulfur
atom, and consequently, ClmM2 should be responsible for the
methylation of the hydroxyl group at position 4 of collismycin in
later steps of the biosynthesis.99–413, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 407
Figure 7. Proposed Pathway for the Biosynthesis of Collismycin A
The different steps in collismycin A biosynthesis with putative assignations for the different enzymes are indicated.
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The gene cluster for the bipiridyl collismycin A has been isolated
and characterized and found to extend along a chromosomal
region of approximately 36 kb. For the isolation of the cluster,
we took advantage of the use of a specific gene probe, the lysine
2-aminotransferase gene, which commits lysine into the bio-
synthetic pathway through the formation of picolinic acid. The
cluster consists of 23 genes: 16 coding for structural proteins;
two coding for pathway regulatory proteins; and five coding for
collismycin secretion. The involvement of the isolated cluster in
collismycin A biosynthesis was confirmed by insertional inactiva-
tion of a hybrid PKS-NRPS gene, and the limits of the cluster
were identified by generatingmutants in flanking genes. Interest-
ingly, database comparisons of the genes of this cluster allowed
the identification of a similar cluster in S. roseosporus, which had
not been annotated as such. Both clusters were identical at
the level of genetic organization and with a very high degree of
identity/similarity (above 93%), suggesting a common evolu-
tionary origin.
Based on the deduced products of the genes involved
in collismycin A biosynthesis and the chemical structures of
the two intermediates isolated from mutants CLMAH and
CLMM1, we propose a pathway for collismycin A biosynthesis
(Figure 7) through three different phases: (1) biosynthesis and
activation of picolinic acid from L-lysine; (2) formation of the
2,20-bipiridyl ring; and (3) modifications of the 2,20-bipyridyl
structure.
In the first phase, picolinic acid would be synthesized from
L-lysine with the participation of two enzymes, ClmL (lysine408 Chemistry & Biology 19, 399–413, March 23, 2012 ª2012 Elsevie2-aminotransferase) and ClmS (oxidase), homologs of which
have been found in other biosynthesis pathways also utilizing
picolinic acid as biosynthesis precursor, such as nikkomycin
and virginiamycin pathways. Picolinic acid would be finally acti-
vated by ClmAL (acyl CoA ligase) to picolinyl-CoA, which would
be then loaded to the hybrid PKS-NRPS enzyme by ClmP, acting
as a loading enzyme. As a result of the action of these enzymes,
the first pyridine ring of collismycin is formed.
Formation of the second pyridine ring would occur in the
second phase and would require the participation of a PKS-
NRPS system, involving two genes (clmN1 and clmN2) for the
incorporation of a malonyl-CoA extender unit, a cysteine and
a leucine. The incorporation of a malonate unit and a cysteine
would be catalyzed by the ClmN1 hybrid PKS-NRPS. The
enzymes catalyzing the proposed reduction steps following
malonyl-CoA incorporation are not yet identified. Interestingly,
the incorporation of the cysteine residue likely occurs byMichael
addition (1,4-addition) of the cysteine rather than the usual direct
1,2-attack at the thioester carbonyl, something very unusual for
NRPS but not for PKS (Mihali et al., 2008). From the chemical
reactivity, a 1,4-Michael addition is clearly preferred over an
1,2-addition, and enzymes usually follow chemical reactivity
logic. Moreover, proposing a Michael addition here also facili-
tates the overall biosynthetic process, by avoiding a chemically
and enzymatically unprecedented and unlikely rearrangement
after the fact. Note that a Michael addition was also proposed
for the first NRPS module reaction in bleomycin biosyn-
thesis (Shen et al., 2002). Along with the cysteine incorporation,
the switch from ACP- to the PCP-tethering occurs. Simulta-
neously with this, we also propose CoA-activation of the formerr Ltd All rights reserved
Chemistry & Biology
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cyclization reaction that happens later. This carbonyl needs to
be activated sooner or later and not necessarily as a CoA ester;
it also could form an anhydride with phosphoric acid (which
would occur through phosphorolysis, like in the well-known
glyceraldehyde-3-phosphate dehydrogenase reaction of glycol-
ysis). That activation likely happens along with the cysteine
incorporation but may happen also later; therefore, the question
mark appears in Figure 7.
The incorporation of an extra amino acid, a leucine, would be
catalyzed by the ClmN2 NRPS. The presence of malonate and
cysteine had been already anticipated based on the structure
of collismycin, on predictions for a possible biosynthesis path-
way, and on amino acid signatures present in the PKS and
NRPSdomains of clmN1. However, the incorporation of a leucine
residue was completely unexpected. Insertional inactivation of
the clmAH amidohydrolase and of the clmM1methyltransferase
genes gave rise to the isolation of two compounds, collismycin
SC and collismycin SN, with masses clearly higher than that of
collismycin A and both containing an extra leucine residue
elongating the cysteine. Both compounds are biosynthetic inter-
mediates (and not shunt products), since they were efficiently
converted to collismycin A when fed to a deletion mutant in the
PKS-NRPS ClmN1. This temporarily bound leucine residue
might help to fit the proposed intermediate into the enzyme
responsible for formation of the second pyridine ring. The effect
of its isobutyl side chain might also contribute to an enhanced
nucleophilicity of ring methylene group next to the sulfur atom
that is necessary for the ring closure. Breakage of the S-N
bond would be catalyzed by the ClmM1 methyltransferase
during the methylation event. This was demonstrated by the
conversion of collismycin SN into collismycin SC when collis-
mycin SN was added to cultures of the CLMAH mutant. The
presence of a third ring in collismycin SN was surprising and
induced us to propose a mechanism in which the formation of
this third ring is necessary for the generation of the 2,20-bipyridyl
structure followed by the breakage of this third ring when the
ClmM1 methyltransferase methylates the sulfur atom. Finally,
for the formation of the 2,20-bipyridyl ring, two oxidations and
one dehydration step would be necessary and catalyzed by
enzymes not yet well defined in the gene cluster.
In the final phase, the leucine residue would be removed by
the ClmAH amidohydrolase followed by the reduction of the
carboxyl group to an aldehyde group (ClmG1 and ClmG2
proteins) and the formation of the oxime by the ClmAT amino-
transferase and finally the methylation of the hydroxyl group at
position 4 by the ClmM2 methyltransferase. The presence of
an oxime function in collismycin A is not very frequent in bacterial
natural products. In plants, the formation of oximes is usually
mediated by members of the cytochrome P450 family (Sibbesen
et al., 1995; Wittstock and Halkier, 2000), and the participation of
the cytochrome P450 NocL in the conversion of a primary amine
to an oxime in nocardicin A biosynthesis has been also reported
(Kelly and Townsend, 2002). In the collismycin A cluster no gene
coding for a cytochrome P450 has been found. We therefore
propose a role for the ClmAT transaminase in the introduction of
the oxime group using either delta-(N)-OH ornithine or epsilon-
(N)-hydroxy-lysine as a donor. Experiments now in progress in
our laboratory are focused on the generation of individualChemistry & Biology 19, 3knock-outs in most of the genes of the cluster in order to clearly
establish a definitive function for the different genes and their
products and the isolation of collismycin A derivatives.
SIGNIFICANCE
Collismycin A is synthesized through a hybrid polyketide
synthase-nonribosomal peptide synthetase (PKS-NRPS)
system, leading to the formation of the 2,20-bipyridyl ring
structure, characteristic of this compound. This biosyn-
thesis process has some particular features not frequently
found inother systems.One is the incorporationof a cysteine
residue, possibly by aMichael addition, which is unusual but
the most logical way for the design of the bipyridyl system
omitting any major rearrangements. Another feature is the
incorporation by a NRPS of a leucine residue that no longer
remains in the final structure but rather is removed by an
amidohydrolase in later steps of the biosynthesis. The pres-
ence of this leucine might facilitate the formation of the
second pyridine ring, as discussed above. The isolation
and characterization of the collismycin A gene cluster opens
up the way for future studies aimed at engineering through
combinatorial biosynthesis to generate analogs of this com-
pound with potentially improved therapeutic activities.
EXPERIMENTAL PROCEDURES
Strains, Culture Conditions, and Plasmids
Bacterial strains used in this work were Streptomyces spp. CS40, collismycin
producer, and Escherichia coli strains DH10B (Invitrogen, Carlsbad, CA, USA)
and ET12567 (pUB307; Kieser et al., 2000) used for subcloning and strain
LE392MP (Epicenter, Madison, WI, USA) used to generate and propagate
the cosmid library. Growth media for Streptomyces strains were tryptone
soya broth (TSB) for propagation growth, a medium for sporulation (Ferna´ndez
et al., 1998), and R5A as production medium (Ferna´ndez et al., 1998). Con-
jugation between E. coli and Streptomyces was performed following standard
procedures (Kieser et al., 2000). E. coli media were those described by
Sambrook et al. (1989). When clones containing antibiotic resistance gene
markers were grown, the medium was supplemented with the appropriate
antibiotics: 100 mg/ml ampicillin, 25 mg/ml apramycin, 25 mg/ml chloram-
phenicol, 50 mg/ml nalidixic acid, 10 mg/ml tetracycline, 50 mg/ml thiostrepton,
and 20 mg/ml tobramycin. Plasmids used in this work were pBluescript II SK+
(Fermentas, Glen Burnie, MD, USA) for routine cloning, pCR-Blunt (Invitrogen)
and pGEM-T (Promega, Madison, WI, USA) for subcloning of PCR products,
and pHZ1358 (Sun et al., 2009) and pOJ260 (Bierman et al., 1992) for gene
replacement and gene disruption experiments in Streptomyces, respectively.
pUO9090 (Prado et al., 1999) was the source of the apramycin resistance gene
aac3(IV) and pWE15 (Stratagene) was used for constructing the cosmid library.
DNA Manipulation
DNA manipulations were performed in accordance with standard procedures
for E. coli (Sambrook et al., 1989) and Streptomyces (Kieser et al., 2000). A
cosmid library of Streptomyces spp. CS40 genomic DNA was constructed.
DNA fragments obtained from a partial Sau3AI digestion were ligated to
BamHI-digested cosmid pWE15, and the resultant recombinant DNA was
packaged using MaxPlax Lamda Packaging extracts (Epicenter) in accor-
dance with the manufacturer’s handbook. After infection of E. coli LE392MP,
the resultant E. coli transductants were selected with ampicillin, picked, trans-
ferred to a 96-well micro-titer plates containg Luria broth medium and
ampicillin to construct the Streptomyces spp. CS40 gene library, and kept
at 20C until use. Clones from the library were replica plated onto Luria
agar plates containing ampicillin, and after overnight growth at 37C, colonies
were transferred to nylon membrane filters for in situ colony hybridization anal-
ysis as described (Sambrook et al., 1989) and screened using labeled probe99–413, March 23, 2012 ª2012 Elsevier Ltd All rights reserved 409
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WI, USA).
DNA Sequencing and Analysis of the Collismycin Gene Cluster
The collismycin gene cluster was located in a DNA region delimited by cosmid
cos1c3 and a 7,748 bp EcoRV/HindIII fragment from cosmid cos3B11 (sites
E–H, Figure 1), which partially overlaps cos1c3. An EcoRV/HindIII fragment
from cosmid cos3B11was cloned into pBluescript II SK+ to generate pBSKB8.
Sequencing was performed on double-stranded DNA templates with the
dideoxynucleotide chain-reaction method (Sanger et al., 1977) and the Cy5
Autocycle Sequencing Kit (Pharmacia Biotech, Piscataway, NJ, USA). An
Alf-express automatic DNA sequencer (Pharmacia Biotech) was used.
Computer-aided database searching and sequence analysis were carried
out with the University of Wisconsin Genetics Computer Group software
(Devereux et al., 1984) and the Blast program (Altschul et al., 1990). Analysis
of PKS and NRPS predicted proteins was carried out using programs
ASMPKS (Tae et al., 2007) and the NRPS predictor (Rausch et al., 2005).
Analysis of transmembrane regions in putative membrane proteins were
carried out using program TMHMM (version 2.0; Krogh et al., 2001).
Construction of Plasmids for Gene Inactivation
Involvement of hybrid PKS-NRPS gene in collismycin biosynthesis was
determined by gene disruption. For this purpose pOJB12 was generated in
the Streptomyces suicide vector pOJ260 (Bierman et al., 1992). pOJB12
was obtained by subcloning a 3.1 kb BamHI fragment from cos1c3 into
pOJ260. This construct was used for generation of mutant strain CLM12.
The boundaries of the gene cluster were determined by inactivation of orf1,
orf2, orf3, orf4, and clmR1 as follows.
(1) orf1. For inactivation of orf1 a 2.1 kb EcoRV/BamHI fragment (sites E–1,
Figure 1) was obtained from pBSKB8 and subcloned into EcoRV site of
pUO9090 to generate pUO2K. Then, a 3.6 kb BamHI (sites 1–2, Fig-
ure 1) fragment obtained from pBSKB8 was subcloned into the
blunt-ended HindIII site of pUO2K to generate pUO2K3K. From this
construct, a 6.5 kb SpeI fragment was rescued (containing orf1 disrup-
ted by the insertion of the aac3(IV) cassette) and cloned into BamHI
blunt-ended pHZ1358 to generate pHZ2K3K that was finally used for
the gene replacement experiment.
(2) orf2. For inactivation of orf2 the 50- and 30-end regions of orf2 were
amplified by PCR. A 1,526 bp fragment from the 50-end was amplified
from cos1c3 using oligoprimers orf22 del1 (50-GAATTCCGGTGAAT
CGTCGCGG-30, EcoRI underlined) and orf22 del2 (50-AAGCTTCGG
CACGCCTCGCGT-30, HindIII underlined). A 1,500 bp fragment from
the 30-end was amplified from cos1c3 using oligoprimers orf22 del3
(50-GATATCGCGTAGCCCGTCCACGG-30, EcoRV underlined and
orf22 del4 (50-GATATCGCTATCTGCTGACCGGCC-30, EcoRV under-
lined). PCR conditions used were 97C, 5 min; 30 cycles of 95C, 30
s, 55C and 68C, 1 min and a final extension at 68C 10 min. Pfx
DNA polymerase (Invitrogen) and 1x PCR Enhancer Solution (In-
vitrogen) were used for all amplifications. The PCR products were
then subcloned into pCR-Blunt and sequenced. The 50-end frag-
ment was recovered by EcoRI/HindIII digestion and subcloned into
pUO9090 to generate pU022A. The 30-end was recovered by EcoRV
digestion and subcloned into pUO22A to generate pUO22AB. From
this construct, a 4.5 kb SpeI fragment was rescued (containing most
of orf2 deleted and substituted by the aac3(IV) cassette) and cloned
into BamHI blunt-ended pHZ1358 to generate pHZ22AB that was
finally used for the gene replacement experiment.
(3) orf3. For inactivation of orf3 the 50- and 30-end regions of orf3 were
amplified by PCR. A 1,589 bp fragment from the 50-end was amplified
from cos1c3 using oligoprimers orf23 del1 (50-GAATTCGCGATCTCGA
GCTCGGCCTT-30, EcoRI underlined) and orf23 del2 50-AAGCTTTTGT
GATCAGTTGAGGCCGGG-3, HindIII underlined). A 1,653 bp fragment
from the 30-end was amplified from cos1c3 using oligoprimers orf23
del3 (50-GGATCCGCATCCTCGACGTGAACCCC-30, BamHI under-
lined) and orf23 del4 (50-GATATCTACTCCAGGGTGCCGTCGGG-30,
EcoRV underlined). PCR conditions were the same as described
above. The PCR products were then subcloned into pCR-Blunt and410 Chemistry & Biology 19, 399–413, March 23, 2012 ª2012 Elseviesequenced. The 50-end fragment was recovered by EcoRI/HindIII
digestion and subcloned into pUO9090 to generate pU023A. The
30-end was recovered by EcoRV/BamHI digestion and subcloned
into pUO23A to generate pUO23AB. From this construct, a 4.7 kb
SpeI fragment was rescued (containing most of orf3 deleted and
substituted by the aac3(IV) cassette) and cloned into BamHI blunt-
ended pHZ1358 to generate pHZ23AB that was finally used for the
gene replacement experiment.
(4) orf4. For inactivation of orf4, a 2,9 kb BamHI fragment (sites 20–21,
Figure 1) from cos1c3 was cloned into pBluescript SK + to generate
pBSKB23. From this construct, a 2.2 kb ClaI/BamHI fragment (sites
C–21, Figure 1) was obtained and cloned into BamHI blunt-ended
pOJ260 to generate pOJB23P. This plasmid was used for the gene
disruption experiment.
(5) clmR1. For inactivation of clmR1, a 3.6 kb BamHI fragment (sites 1–2,
Figure 1) from pBSKB8 was cloned into the BamHI site of pBluescript II
SK + to generate pBSK3K. Then, the aac3(IV) cassette from pUO9090
was rescued with HindIII/EcoRV, blunt-ended and cloned into the
blunt-ended NcoI site (site N, Figure 1) of the previous construct
pBSK3K generating pBSK3KA. From this construct, a 5.1 kb NotI/
EcoRI fragment was recovered, blunt-ended and cloned into BamHI
blunt-ended pHZ1358 to generate pHZ3KA. This plasmid was used
for the gene replacement experiment.
Two additional mutants were generated in the clmAH and clmM1 genes as
follows.
(1) clmAH. A 1,504 bp fragment upstream clmAH was amplified by PCR
using oligoprimers orf13 del1alt (50-CTGCACACGGCCGTCAC-30)
and orf13 del2 (50-GGTGCTACGCCTCCACG-30), using the PCR con-
ditions described above. The PCR product was subcloned into
pCR-blunt and sequenced. This construct was then digested with
EcoRI and a 1.5 kb fragment subcloned into pUO9090 to generate
pUO13A. Then, a 1.9 kb EcoRI/PvuI fragment from cos1c3 (sites
EI–P, Figure 1) was blunt-ended and cloned into pCR-blunt vector.
This construct was verified by sequencing, and the 1.9 kb EcoRI frag-
ment recovered and cloned into EcoRV-digested pUO13A to generate
pUO13AB. From this construct, a 4.9 kb SpeI fragment was recovered,
blunt-ended and cloned into BamHI blunt-ended pHZ1358 to generate
pHZ13AB. This plasmid was used for gene replacement experiment.
(2) clmM1. For inactivation of clmM1 the 50- and 30-end regions of clmM1
were amplified by PCR. A 1,597 bp fragment from the 50-end was
amplified from cos1c3 using oligoprimers orf9 del1 (5-GAATTCTGGA
CGAGGACGGTCAGGAGG-30, EcoRI underlined) and orf9 del2 (50-AA
GCTTATGCTCCATCAGTCCCGACACGA-30, HindIII underlined). A
1,542 bp fragment from the 30-end was amplified from cos1c3 using
oligoprimers orf9 del3 (50-TTGTACCGGGGTAGCCGTCGC-30) orf9
del4 (50-CGAGTTCAAGCCGGTACGGGAGT-30). PCR conditions were
the same as described above. The PCR products were then subcloned
into pCR-Blunt and sequenced. The 50-end fragment was recovered by
EcoRI/HindIII digestion and subcloned into pUO9090 to generate
pU09A. The 30-end was recovered by EcoRI digestion and subcloned
into pUO9A to generate pUO9AB. From this construct, a 4.6 kb SpeI
fragment was rescued (containing most of clmM1 deleted and
substituted by the aac3(IV) cassette) and cloned into BamHI blunt-
ended pHZ1358 to generate pHZ9AB that was finally used for the
gene replacement experiment.Generation of Streptomyces spp. CS40 Mutant Strains
Constructs pOJB23P and pOJB12 were introduced into Streptomyces spp.
CS40 by intergeneric conjugation from E. coli ET12567 (pUB307). Transcon-
jugants were selected for resistance to apramycin and integration into the
Streptomyces spp. CS40 chromosome verified by Southern hybridization.
Constructs pHZ2K3K, pHZ22AB, pHZ23AB, pHZ3KA, pHZ9AB, and
pHZ13AB were introduced into Streptomyces spp. CS40 by intergeneric con-
jugation from E. coli ET12567 (pUB307). Transconjugants, in which the double-
crossover event took place, were identified by their resistance to apramycin
and sensitivity to thiostrepton and verified by Southern hybridization.r Ltd All rights reserved
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Routinely, collismycin production was assessed by cultivating Streptomyces
spp. CS40 or mutants on R5A solid production medium. After six days at
30C, agar plugs containing 1.5 ml agar media were extracted with 1.5 ml ethyl
acetate/1% formic acid, and the presence of collismycin or related com-
pounds in the extracts were analyzed by ultra-performance liquid chromatog-
raphy (UPLC). In liquid cultures, strains were grown as a seed culture in TSB
(30 ml in a 250 ml Erlenmeyer flask). After two days incubation in a rotary incu-
bator (30C, 250 rpm), 2.5% v/v of the cultures were used to inoculate 30 ml
R5A liquid medium. After seven days of incubation, 1 ml aliquots of fermenta-
tion brothswere removed, and 1ml ethyl acetate/1% formic acid was added to
the sample and mixed vigorously for 30 min. The phases were separated by
centrifugation and then the ethyl acetate removed by evaporation using
a Speed-Vac. Residues were resuspended in methanol and clarified by centri-
fugation. Analysis of collismycin production was performed by reversed-phase
chromatography on Acquity UPLC equipment with a BEH C18 column
(2.13 100 mm; Waters, Milford, MA, USA) with acetonitrile and 0.1% trifluoro-
acetic acid (TFA) as eluent. Samples were eluted with 10% acetonitrile for
1 min, followed by a linear gradient from 10% to 80% acetonitrile over 7 min
at a flow rate of 0.5 ml/min and a column temperature of 30C. For high-
performance liquid chromatography-mass spectrometry, an Alliance chro-
matographic systemcoupled to aZQ4000mass spectrometer and aSymmetry
C18 column (2.1 3 250mm; Waters) were used. Solvents were the same as
listed previously, and elution was performed with an initial isocratic hold with
10% acetonitrile for 4 min followed by a linear gradient form 10% to 88%
acetonitrile over 26 min at 0.25 ml/min. MS analyses were done by electro-
spray ionization in the positive mode, with a capillarity voltage of 3 kV and
a cone voltage of 20 V. Detection and spectral characterization of peaks
was performed in both cases by photodiode array detection and Empower
software (Waters), extracting bidimensional chromatograms at 332 nm.
Isolation of Collismycins SN and SC
Collismycins SN and SC were purified from 2.4 L cultures of Streptomyces
spp. mutants CLMM1 and CLMAH, respectively, following culture conditions
described previously. The extracts were dissolved in 5 ml of a mixture of
dimethyl sulfoxide (DMSO) and methanol (1:1) and centrifuged, and the
resulting upper lipid layer was removed. The first purification step was done
by chromatography in an XTerra PrepRP18 column (19 3 300 mm; Waters)
with acetonitrile and 0.05% TFA in water as solvents. A linear gradient from
30% to 100% acetonitrile in 7 min followed by a 30 min isocratic hold with
100% acetonitrile was used, at a flow rate of 15 ml/min. Peak of interest
was collected in 0.1 M phosphate buffer (pH 7.0). The solution obtained was
partially evaporated in rotavapor to reduce the acetonitrile concentration
and then applied to a solid-phase extraction cartridge (Sec-Pak C18; Waters),
washed with water to remove salts and eluted with methanol. Further purifica-
tions were performed in isocratic conditions with a Symmetry C18 column
(7.83 300mm;Waters), usingmixtures of acetonitrile and 0.05%TFA in water,
at flow rate of 7 ml/min. As described above peaks were always collected on
buffer, desalted by solid-phase extraction and finally, to remove the TFA
bound to collismycins, the cartridge was washed with 0.1% ammonia in water,
and after further washing with water, the retained compounds were eluted with
methanol and again lyophilized.
Biotransformations
Biotransformation experiments were carried out in 24 square, deepwell plates
(Enzyscreen, Leiden, The Netherlands). Streptomyces spp. CS40 wild-type
strain and mutants CLMM12, CLMAH, and CLMM1 were grown as seed
cultures in 2 ml of TSB. After 24 hr in an orbital shaker at 30C and 250 rpm,
0.1 ml of each culture was used to inoculate 3 ml of R5A or R5A supplemented
with 0.1 mg of collismycin SN or collismycin SC. After six days of further
incubation (30C/250 rpm), 2 ml of cultures were extracted with 2 ml ethyl
acetate/1% formic acid and were analyzed by UPLC.
Structure Elucidation and Characterization
of Collismycin Derivatives
The structures of the collismycin derivatives were elucidated by NMR spec-
troscopy and mass spectrometry. NMR data were recorded in DMSO-d6 at
298 K using a Bruker Avance Ultrashield Plus 600 spectrometer (600MHz forChemistry & Biology 19, 31H, 150MHz for 13C experiments) and subsequently processed using the pro-
gram Topspin (version 1.3; Bruker GmbH, Karlsruhe, Germany). The chemical
shifts are given in delta (d) values and the coupling constants (J) in Hertz (Hz).
All NMR assignments are based on H,H-COSY, HSQC, HMBC, and NOESY
spectra, allowing an unambiguous assignment of all NMR signals.
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